By Byron Kaye

U.S. private equity giant Bain Capital has hired Reunion Capital Partners to advise on a listing of Australian accounting software firm, MYOB Ltd, worth up to A$3 billion ($2.58 billion), a source familiar with the deal said.

Bain is also expected to hire Bank of America Merrill Lynch, Citigroup, Goldman Sachs and UBS AG to run what would be one of the country's biggest initial public offerings of 2015, said the source who could not be named because of the sensitivity of the arrangements.

The listing is expected to take place in the first quarter of calendar 2015, and the A$3 billion market capitalisation includes a significant stake in the company which Bain plans to keep, the source added.

Bain was not immediately available for comment.

Bain had been widely reported to be seeking an exit from MYOB for months, but the appointment of boutique financial services firm Reunion and the expected appointments of joint lead managers confirm that the Boston-based investor has settled on a timetable and picked a share market listing over a private sale.

It also signals continuing support for Australian IPOs following strong performances from large listings like that of hospital operator Healthscope Ltd, which raised A$2.25 billion and has seen its shares rise 18 percent since July.

Even larger health insurer Medibank Private Ltd, which is scheduled to list on Nov. 25 with an expected market capitalisation of more than A$5.5 billion, upped its share price target following high demand.

The MYOB listing, if it values the firm at A$3 billion, would represent a more than doubling of Bain's investment after it bought the company from Australian private equity firm Archer Capital for A$1.2 billion in 2011.

In August, MYOB reported earnings before interest, tax, depreciation and amortisation grew by 29 percent to A$70 million for the six months to June 30, as revenue rose 21 percent to A$140 million. The company did not give forecasts.

MYOB and Reunion were not immediately available for comment. Goldman Sachs, UBS and Citigroup were unavailable for comment while Bank of America Merrill Lynch declined comment.

 

Related Articles

CC, Davis Polk act on ChaPanda’s $330 mln Hong Kong IPO

by Charlie Wu 吴卓言 |

Davis Polk & Wardwell and Jingtian & Gongcheng have advised Sichuan Baicha Baidao, a Chinese low-priced tea chain also known as ChaPanda, on its $330 million IPO on the Hong Kong Stock Exchange, with Clifford Chance and King & Wood Mallesons acting for the sponsor CICC and underwriters.

Skadden, AMT, MHM, Davis Polk advise on Trial Holding’s $258 mln Japan IPO

by Nimitt Dixit |

Skadden, Arps, Slate, Meagher & Flom and Anderson Mori & Tomotsune have advised Japanese discount-store chain operator Trial Holdings on its $258 million initial public offering on the Tokyo Stock Exchange (TSE), the largest IPO of the year so far.

Cleary, Freshies lead on China shoemaker’s planned $1 bln HK IPO

by Rowena Muñiz |

Cleary Gottlieb Steen & Hamilton and JunHe are advising Chinese footwear and apparel maker Belle Fashion Group on its planned Hong Kong IPO that is set to raise between $500 million and $1 billion. Freshfields Bruckhaus Deringer and Haiwen & Partners are representing the joint sponsors.